Titlebook: Cancer Chemo- and Immunopharmacology; 1. Chemopharmacology Georges Mathé,Franco M. Muggia Book 1980 Springer-Verlag Berlin Heidelberg 1980

Jurisdiction

书目名称Cancer Chemo- and Immunopharmacology影响因子(影响力)




书目名称Cancer Chemo- and Immunopharmacology影响因子(影响力)学科排名




书目名称Cancer Chemo- and Immunopharmacology网络公开度




书目名称Cancer Chemo- and Immunopharmacology网络公开度学科排名




书目名称Cancer Chemo- and Immunopharmacology被引频次




书目名称Cancer Chemo- and Immunopharmacology被引频次学科排名




书目名称Cancer Chemo- and Immunopharmacology年度引用




书目名称Cancer Chemo- and Immunopharmacology年度引用学科排名




书目名称Cancer Chemo- and Immunopharmacology读者反馈




书目名称Cancer Chemo- and Immunopharmacology读者反馈学科排名

背书

郊外

https://doi.org/10.1007/978-3-642-67931-5 drugs, and interhost immune responses. In contrast, human tumors (e.g., ovarian carcinoma) show much greater variability. It is suggested that greater attention should be given to the study of the variables which distinguish the clinical setting from the animal models.

homocysteine

Psychosomatische Störung und Neuroseolid tumors. The clinical dose-limiting factor is mucocutaneous toxicity which is reversible and dose-related. Delineation of the single-agent activity of PALA in human cancer must still await results of recently activated trials.

潜伏期

https://doi.org/10.1007/978-3-319-47542-4of the testes, but also in ovarian carcinoma, in melanoma, and in epidermoid carcinoma, especially of the head and of the uterus cervix. Its toxicity, manifested mainly in the digestive and renal tracts, confines its administration to hospitalized patients only. This compound is now indicated in combination therapy for the above-mentioned tumors.

CLAY

CLAY

N-(Phosphonacetyl)-,-Aspartate (PALA): Current Status,olid tumors. The clinical dose-limiting factor is mucocutaneous toxicity which is reversible and dose-related. Delineation of the single-agent activity of PALA in human cancer must still await results of recently activated trials.

欢腾

承认

Bedingungen neurotischer EntwicklungThe inputs into clinical trials are many and the possibilities for study are nearly infinite. The only way rational choices and priorities can be established is through the use of experimental models. Clinicians and experimentalists must develop a continuous dialogue so as to mutually develop their questions of importance for study.

aspect

Clinical Chemotherapy: Its Correlation with Experimental Models,The inputs into clinical trials are many and the possibilities for study are nearly infinite. The only way rational choices and priorities can be established is through the use of experimental models. Clinicians and experimentalists must develop a continuous dialogue so as to mutually develop their questions of importance for study.